Click to close

Contact us

Please complete the required fields.

*Required Fields

Send

US Toll-free: 1-888-286-4003 International: 1-978-347-1143 contact@visresearch.com

Click to close

Request a Demo

Please complete the required fields.

*Required Fields

Request a Demo

US Toll-free: 1-888-286-4003 International: 1-978-347-1143 contact@visresearch.com

Click to close

Report Problem

Please complete the required fields.

*Required Fields

Send

US Toll-free: 1-888-286-4003 International: 1-978-347-1143 contact@visresearch.com

Login

Click to close

Please complete the required fields.

Forgot your password? Register

Tell us your email address and we'll send you instructions on how to reset your password.

Click to close

Resolution not supported

Click to close

Saving...

 0%

Institutul de Pneumoftiziologie Marius Nasta

Şoseaua Viilor 90, Sector 5, Bucureşti, Bucureşti - Ilfov
050159
Romania
Website | ViS Profile

Center Profile Completeness

About
- Center
- Location
Infrastructure
- General
- Disease-Specific
Patients
- General
- Disease-Specific
Team
- Personnel
- Investigators
Expertise
- General
- Disease-Specific
Research
- Trials
- Publications
Network
- Disease-Specific

Trials in this area

- MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects (GlaxoSmithKline; NCT01691859; Year 2012)

- QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study (Novartis Pharmaceuticals; NCT01782326; Year 2013)

- A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (GlaxoSmithKline; NCT01817764; Year 2013)

Investigators in this area

  • Miron Bogdan
  • Florin Mihaltan
  • Roxandra Ulmeanu
  • Paul Stoicescu

Diseases in this area

  • Sleep Apnea
  • COPD
  • Sinusitis
  • Asthma
  • Pulmonary Hypertension
  • Peripheral Vascular Disease
  • Pulmonary Embolism
  • Pulmonary Vascular Disorder

Click to close
Click to close

Add to network